End-to-end Clinical Partnership
We’re more than a service provider—we walk with you from concept to clinical validation, combining scientific insight with operational excellence to bring your innovation to life.
Science that moves lives forward
From hypothesis to human impact
Accelerating clinical validation through rigorous trials and regulatory insight.
We understand the pace and constraints of research-driven teams. Our flexible, responsive approach is built to support startups, biotech, medtech, and academic innovators from the ground up.
We’re more than a service provider—we walk with you from concept to clinical validation, combining scientific insight with operational excellence to bring your innovation to life.
We don’t just manage compliance—we help you anticipate regulatory requirements and design smarter, more aligned development strategies from day one.
From protocol design to final analysis, our statisticians support the full lifecycle of your study—ensuring your data has integrity, reliability, and is ready for regulatory review.
Our Core Lab offers rigorous standardized protocols, quality control, and seamless integration with your trial operations ensuring consistent, unbiased data across multicenter studies.
We help you turn real-world data into clear, actionable insights that strengthen regulatory submissions, guide clinical strategy, and support market access at every stage.
Your innovation deserves a partner who understands the science and the path to approval.
Stay up to date with the latest news, research, and perspectives shaping clinical development and regulatory science.
The CHOICE-2 randomized clinical trial, coordinated by Hospital Clínic Barcelona and IDIBAPS, has been published in JAMA (Journal of American Medical Association). The study demonstrates that administering intra-arterial alteplase immediately after mechanical thrombectomy significantly improves functional outcomes in severe ischemic stroke. The centralized analysis of brain imaging data across the 14-site Spanish trial was conducted by the BCCC Imaging Core Lab. Key Results Among the 440 patients enrolled,… Read more »
Barcelona Clinical Coordinating Center (BCCC), the lead non-profit contract research organization (CRO) coordinating patient recruitment and clinical operations, announces the completion of patient enrollment in the ANGIODAPT-01 trial, a randomized controlled study evaluating an abbreviated dual antiplatelet therapy (DAPT) regimen following drug-eluting stent implantation. The trial has been sponsored by iVascular, a company developing innovative… Read more »
Barcelona Clinical Coordinating Center (BCCC), the non-profit contract research organization responsible for clinical coordination and patient recruitment, announces the completion of enrollment in the OPAL study, a first-in-human and pivotal clinical study evaluating the novel embolic liquid system Amber, sponsored by iVascular, a company developing innovative advanced medical devices and therapies for the treatment of… Read more »
The future of health is built by those bold enough to test it. We're here to help you prove it